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Asthma in preschool children is greatly under-diagnosed worldwide. Aim was to investigate
prevalence of wheezing, and asthma risk factors, doctor diagnosis, treatment and health
resource utilization in preschool children.
About 1402 children (3e5 years) attending local kindergartens participated in the study.
The International Study of Asthma and Allergies in Childhood (ISAAC) written questionnaire
(WQ) was used with additional questions on risk factors, asthma diagnosis, treatments,
resource utilization. Allergic sensitisation was evaluated by skin prick tests for the common
allergens.
Prevalence of ‘‘wheezing in previous 12 months’’ and ‘‘doctor diagnosed asthma’’ were
12.1% and 8.6%, respectively. 4.7% of children have had both wheezing in the last 12
months and asthma diagnosis. Significant risk factors for wheezing were rhinitis, parental
history of atopy and sensitivity to mites and grass pollens. 27.3% of children with asthma
diagnosis, but only 4.9% of children without diagnosis, received regular treatment during
the previous year (p< 0.0001). Children with more than 4 episodes of wheezing a year
received more frequently an asthma diagnosis, but 68.6% were not on regular treatment.
Asthma diagnosis was associated with a significant increase in control visits for wheezing
(p< 0.0001). The prevalence of children requiring at least one hospital emergency visit
in the previous year was not different among the two groups (83.3% vs. 82.5%).
In preschool children the prevalence of wheezing and asthma is elevated. Preschool
asthma seems to be under-treated with few cases receiving regular therapy. The social cost
of the disease at this age seems to be elevated because of the high frequency of control
and emergency visits.
ª 2008 Elsevier Ltd. All rights reserved.45 8124744.
linet.it (D.G. Peroni).
8 Elsevier Ltd. All rights reserved.
Preschool asthma in Italy 105Introduction
In UK, more than 20 years ago, it was reported that asthma
in children is under-diagnosed and under-treated even in
severely affected patients.1 The same problem was later
described in other countries, particularly in girls.2e4 This
was found to be associated with lost days at school1,2 and
with increased risk of emergency room visits and hospital
admissions.5,6
Since then, several guidelines have been published for
asthma diagnosis and management,7,8 which have been
translated into different languages and widely distributed
to physicians. After the production of the first guidelines it
was soon clear that there was the need to ameliorate
adherence to guidelines since no greater improvement in
asthma diagnosis and treatment was observed.9 Risk factors
for wheezing and asthma have been studied extensively in
school age children but there is little information about
younger children.10 Therefore, aim of the present study
was to investigate the prevalence of wheezing and doctor’s
asthma diagnosis and the relevance of risk factors for
wheezing in 3e5-year old children. Treatments and
resource utilization according to symptoms and/or diag-
nosis have also been investigated.
Methods
This was a cross-sectional study in 3e5-year-old children,
performed by the use of the International Study of Asthma
and Allergies in Childhood (ISAAC) written questionnaire
(WQ)11 with added questions on risk factors, doctor diag-
nosis, resource utilization and asthma exacerbations.
Eighteen nursery private schools located in the munici-
pality of Verona, a town in northern Italy, were randomly
selected from the complete sampling frame of all private
kindergartens of the area (being about 80 the total number
of nursery schools). All children attending the school aged
3e5 years were considered suitable for the study.
A 16-page questionnaire was issued at school for
completion by parents at home. WQ contained the three
core ISAAC modules asking about symptoms of asthma,
atopic dermatitis and allergic rhinitis.11 Additional ques-
tions concerning breastfeeding for at least 4 months,
parental atopy, presence of cigarette smokers (‘‘Is the
mother and/or father smoking inside home?’’) and furred
pets at home were asked. Parental atopy was defined as
a positive response to the question ‘‘has the father or the
mother ever suffered from allergic asthma, rhinitis or
eczema?’’. An asthma exacerbation was defined as
a wheezing episode that required either doctor urgent visit,
or emergency department visit, or systemic corticosteroids
besides bronchodilators.
Atopic status was assessed at school by skin prick tests
(SPT) for common allergens. Standardized extracts for
foods (egg, milk), pollens (Grass mix, Parietaria judaica),
house dust mites (Dermatophagoides pteronyssinus and
Dermatophagoides farinae), animal dander (cat, dog),
Alternaria, as well as a saline negative control and
a histamine control (10 mg/ml) (ALK-Abello’, Milan, Italy),
were used. A wheal diameter 3 mm greater than the
negative control was considered as a positive response.12Analysis of data
For all analyses p values<0.05 were regarded as statistically
significant. Prevalence rates were presented with their 95%
confidence interval (95% CI). Chi-square tests were used to
compare proportions between children with wheezing or
diagnosed asthma vs. those without wheezing or diagnosed
asthma, respectively. The strength of the association
between lifetime wheezing, wheezing in the last 12 months,
diagnosed asthma, rhinitis, atopic dermatitis, allergic
sensitisation and positive family history for atopic diseases
was expressed by odds ratio (OR), with their 95% confidence
interval, unadjusted and adjusted by sex and age.
Logistic regression analyses were conducted to identify
independent risk factors for wheezing in the last 12 months
and for diagnosed asthma. All supposed risk factors were
included in the initial model; the risk factors with the
lowest Wald chi-square were then excluded, one at a time,
until only variables with a p values <0.05 remained.
Chi-square tests were also used to compare demographic
and clinical characteristics of respondents without and with
SPT in order to assess the likelihood of selection bias.
All statistical analyses were performed using SAS
(Version 6.12).
Approval for the study was obtained from the Hospital
Committee and informed consent was obtained from
children’s parents. The family doctors were also informed
and received a letter regarding the child conditions.
Results
About 1402 valid WQ (92%) (734 males and 668 females)
were returned for evaluation.
SPT were performed in 1121 children whose parents gave
written consent for this evaluation (response rate 79.9%).
Characteristics of the study population are shown in Table 1,
where data on prevalence of parental atopy, breastfeeding,
exposure to cigarette smoking and allergen sensitisation are
indicated.
Prevalence of wheezing symptoms, asthma, rhinitis and
eczema diagnosis are included in Table 2. Prevalence of
‘‘wheezing ever’’ in the total study population was 25.9%,
ranging from 19.2% in the youngest group, to 25.6% in the 4-
year-old group, and to 29.5% in the oldest group. The
prevalence of ‘‘wheezing in the last 12 months’’ was 10.9%
at age 3, 13.5% at age 4 and 11.6% at age 5. The ‘‘diagnosis
of asthma’’ was present in 8.6% of the whole study pop-
ulation, with a trend towards increasing with age (5.6%,
8.6% and 11.9% in the 3-, 4- and 5-year-old group, respec-
tively). Doctor diagnosis of asthma was more than double in
boys from age 3 to age 5.
Table 3 indicates the asthma treatment and resource
utilization in wheezing children with (no 66) and without
(no 103) asthma diagnosis by a doctor. Children presenting
more than four acute exacerbations in the last year were
significantly more likely to be diagnosed as asthmatics. In
fact this was the case in 28.2% in the group of diagnosed
asthmatic children vs. 15.5% of those reporting wheezing
without an asthma diagnosis (p< 0.05).
Considering asthma treatment and resource utilization,
there was a significant difference in the regular use (at
Table 1 Characteristics of the total study population (1402 children).
Children
aged
3 years,
No (%)
Children
aged
4 years,
No (%)
Children
aged
5 years,
No (%)
Gender
males/
females
No (%)
Prevalence
of parental
atopy mother/
father No (%)
Children
breastfed
for at least
4 months
No (%)
Exposure
to cigarette
at home
No (%)
Children
sensitized
to mites
(1121 tested)
No (%)
Children
sensitized to
Grass pollen
(1121 tested)
No (%)
519 (37.0) 472 (33.7) 411 (29.3) 734/668
(52.4/47.6)
173/155
(12.3/11.0)
1137 (81.4) 601 (42.9) 79 (7.0) 73 (6.5)
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groups. 27.3% of children with an asthma diagnosis received
regular prescription during the last year, while this was the
case for only 4.9% of those without diagnosis (p< 0.0001).
However, 68.6% of children with persistent wheezing pre-
senting more than 4 exacerbations in the past year were not
receiving regular treatment. This occurred despite the fact
that control visits respiratory symptoms were more likely to
be scheduled in children with diagnosed asthma in
comparison to children without such a diagnosis. Children
who received at least a control visit for wheezing in the last
12 months by the family doctor were 60.6% and 17.5% in
diagnosed and non-diagnosed cases, respectively
(p< 0.0001). Interestingly, the prevalence of children
requiring at least one hospital emergency visit in the
previous year was not different among the two groups
(83.3% vs. 82.5%).
68.2% of children with asthma diagnosis and 50.5% of
children with wheezing but not asthma diagnosis missed
days at the nursery school because of respiratory symptoms
(pZ 0.02). Moreover, no statistically significant difference
in workdays lost by the parents for the respiratory symp-
toms of their children was observed between groups, 36.4%
and 26.2%, respectively.
Risk factors are reported in Table 4. Significant risk
factors for wheezing in the last year were rhinitis, parental
history of allergic diseases, atopy defined by sensitivity to
mites or to grass pollens and atopic dermatitis.
Relevant risk factors for having a ‘‘doctor diagnosis of
asthma’’ were the presence of rhinitis and having parental
history of allergic diseases (adjusted odds ratio 4.45, 95% CI
2.55e7.75 and 2.64, 95% CI 1.60e4.35, respectively). No other
significant factor was noted; in particular, asthma diagnosis
was not influenced by gender and by age of children.Discussion
Several studies have demonstrated that children can be
screened for asthma and respiratory allergies byTable 2 Prevalence of wheezing symptoms, asthma, rhinitis an
Wheezing Rhinitis
Ever
(%)
Last 12
months (%)
Asthma
diagnosis (%)
Ever
(%)
Last
mon
No of
children (%)
354
(25.2)
169
(12.1)
121
(8.6)
258
(18.4)
236
(16.questionnaires both at school11,12 and at the preschool10
age. The prevalence of wheezing and asthma in northern
Italy has been investigated even in larger sample sizes by
another cross-sectional study, the SIDRIA study.13 However,
the SIDRIA study assessed older children (age 6e7) and
provided data on prevalence of ‘‘asthmatic bronchitis’’
(defined as a positive response to the question ‘‘In the first
two years of life, did a doctor say that your child had
bronchitis/asthmatic bronchitis/pneumonia?’’), which may
have been exposed to recall bias.13 The present study
investigated wheezing prevalence, asthma diagnosis and
risk factors in a preschool children population, an age group
for whom little information is available on literature.10 Our
results clearly show that some children with symptoms are
not diagnosed and therefore may be under-treated. At this
regard regular use of anti-asthma medications was
prescribed in 27.3% of children with current symptoms and
asthma diagnosis by family doctor, and only in 4.9% of
wheezing children without a diagnosis of asthma. In the
questionnaire anti-asthmatic drugs were defined as drugs
given by the doctor to prevent or alleviate bronchocon-
striction in children, including bronchodilators in associa-
tion with inhaled steroids and leukotriene receptor
antagonists. We recognize that the actual guidelines8 and
position paper14 prescribe a different approach to the
infant wheezer, but this question was adopted for our
epidemiological investigation because it was easily under-
standable by parents.
There is clearly a lot of space for improvement because,
even if 60% of children with symptoms and asthma diagnosis
received periodical control visits, 82% of them required at
least one emergency department visit in the last year.
Unfortunately, an improved diagnosis rate is not always
followed by an improvement in treatment, with consequent
frequent exacerbations and hospital admissions. This is
evident in the preschool children population of the present
study since there was no difference in hospital emergency
visits between children in the group with asthma diagnosis
and children without diagnosis. We have to consider at this
age that the non-allergic viral-induced wheezing, which isd eczema diagnosis.
Eczema
12
ths (%)
Doctor
diagnosis (%)
Ever
(%)
Last
12 months (%)
Doctor
diagnosis (%)
8)
56
(4.0)
294
(21.0)
254
(18.1)
216
(15.4)
Table 3 Asthma treatment and resource utilization in wheezing children with and without asthma diagnosis.
Total wheezing children
with doctor’s asthma
diagnosis (66) No (%)
Total wheezing children
without Doctor’s asthma
diagnosis (103) No (%)
Statistical
significance
Children using regularly anti-asthmatic
drugs in the last 12 months
18 (27.3) 5 (4.9) P< 0.0001
Children attending GP’s control visits for
wheezing in the last 12 months
40 (60.6) 18 (17.5) P< 0.0001
Children referred to hospital emergency
visits for respiratory problems
55 (83.3) 85 (82.5) n.s.
Children presenting more than 4 episodes
of wheezing in the last 12 months
19 (28.2) 16 (15.5) P< 0.05
Children missing days at school because
of wheezing
45 (68.2) 52 (50.5) PZ 0.02
Children whose parents loose workdays
because of children’s wheezing
24 (36.4) 27 (26.2) n.s.
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may determine wheezing re-exacerbations irrespective to
treatment.
It has been previously observed that parents and
physicians frequently underestimated the severity of
their child’s/patient’s asthma.15,16 Moreover, it has been
observed that symptoms alone do not entirely reflect
disease severity and that multiple variables including
lung function and drug consumption need to be consid-
ered in the classification of disease severity.17 Almost
none of our wheezing children had a lung function eval-
uation despite the fact that reproducible and valid
forced expirations can be obtained in 50e90% of 3e5
year-old children.18,19 More frequent use of spirometry
may provide additional benefits in individual patient
management and may provide informations concerning
the risk of asthma attacks.20 The selection of symptoms
is also important. Physicians always enquire about
wheezing, but nocturnal symptoms more than wheeze
classifies the majority of patients as severe andTable 4 Multiple logistic regression analysis of risk factors
for wheezing in the last 12 months.
Risk factor Adjusted odds ratio 95% CI
Significant risk factors (final model)
Rhinitis 2.41 1.60e3.65
Mite sensitisation 1.91 1.06e3.45
Parental historya 1.72 1.01e2.93
Pollen sensitisation 1.63 1.12e2.39
Atopic dermatitis 1.59 1.06e2.38
Non-significant risk factors (initial model)
Parents’ smoking 1.15 0.79e1.67
Gender (male)b 1.11 0.76e1.62
Breastfeeding 1.09 0.67e1.78
Pets at home 0.96 0.40e2.29
Age 0.92 0.73e1.17
Bedroom shared 0.77 0.49e1.21
a Familiarity for asthma, hay fever, eczema.
b Female is reference category.persistent.21 Thus, paediatricians may fail to ask the
right questions, not only before the diagnosis of asthma is
established but also during follow-up of the disease. In
a survey of paediatricians and family physicians con-
cerning the questions they asked to asthmatic patients
about their clinical progress during a consultation,
a substantial proportion did not ask about the child’s
functional status, and at least 40% did not ask routinely
about exercise-induced bronchospasm.22 It is now clear
that asthma control cannot be inferred from the clinical
measures of airway function alone and that patients’
assessment has to be broadened to include factors such
as the impact of disease on everyday functioning and role
of performance.23 In practice, once the diagnosis of
asthma is established, a framework of questions con-
cerning the complex burden of the disease24 should be
routinely adopted for anticipatory guidance supervision
of the asthmatic children and their parents.25 A better
understanding of the burden of the disease by patients
and parents may significantly improve their compliance
and adherence to asthma prescriptions and guidelines.
Furthermore it is clear that also recognizing risk factors
the diagnosis and treatment of asthma and of other
allergic diseases can be improved. Our study confirms and
further extends the role of familial and personal history
of allergy, leading to consider as crucial the role of
allergic sensitisation even in this age group.10
In conclusion, in preschool asthma further attempts to
improve adherence and implementation to asthma guide-
lines either for diagnosis or for treatment are needed. For
this reason, several factors which span from poor percep-
tion of symptoms both from the children and from their
parents as well as to provider underestimation of asthma
severity and control should be taken into consideration.
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